Skip to main content
OpenTrials

Clinical trial condition

Primary Peritoneal Cavity Cancer

Explore clinical trials studying Primary Peritoneal Cavity Cancer. Study availability and eligibility vary by location and protocol.

95 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Primary Peritoneal Cavity Cancer trial results

Completed

Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00114166

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
View all 78 locations
View Trial Details
Completed

Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

NCT00459290

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Kaiser Permanente Medical Center - Los Angeles Los Angeles, California, United States
  • Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain, Connecticut, United States
  • Hinsdale Hematology Oncology Associates Hinsdale, Illinois, United States
View all 22 locations
View Trial Details
Completed

Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

NCT00569673

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus New Britain, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
View all 37 locations
View Trial Details
Completed

S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00872989

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • NEA Medical Center - Stadium Boulevard Jonesboro, Arkansas, United States
View all 137 locations
View Trial Details
Completed

Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer

NCT00769405

Conditions
Abdominal Neoplasms, Colonic Diseases, Colonic Neoplasms, +15 more
Locations
  • Centre Paul Papin Angers, France
  • Hôpital Antoine Béclère Clamart, France
  • CHU Estaing Clermont-Ferrand, France
  • Louis Mourier Hospital Colombes, France
View all 20 locations
View Trial Details

Related conditions